Atovaquone + proguanil: new indication. For children weighing as little as 5 kg; an inconvenient form. A flavoured syrup would be better suited to infants and young children.
D000284:Administration, Oral; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D053626:Atovaquone / Q000008:administration & dosage / Q000627:therapeutic use*; D001835:Body Weight; D002626:Chemistry, Pharmaceutical; D002648:Child; D002675:Child, Preschool; D004304:Dosage Forms; D004334:Drug Administration Schedule; D017277:Drug Approval; D004338:Drug Combinations; D005602:France; D006801:Humans; D007223:Infant; D008288:Malaria / Q000188:drug therapy*; D016778:Malaria, Falciparum / Q000188:drug therapy; D002727:Proguanil / Q000008:administration & dosage / Q000627:therapeutic use*; D013607:Tablets / Q000008:administration & dosage / Q000627:therapeutic use
D000962:Antimalarials; D004304:Dosage Forms; D004338:Drug Combinations; D013607:Tablets; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone